Labixiaoxin Snacks Group Limited (LABIXIAOXIN) reported that, for the month ended 31 March 2026, its issued share base rose by 20.83 million ordinary shares—or 9.5 %—to 239.25 million shares.
The increase stemmed from a consideration issue completed on 31 March 2026, previously authorised at the company’s 19 June 2025 general meeting. The new shares were allotted at HKD 3.98 each.
Authorised share capital remained unchanged at 500 million ordinary shares with a par value of HKD 0.001, representing total authorised capital of HKD 0.50 million. No treasury shares were held before or after the transaction, and no share repurchases or cancellations were recorded during the month.
Following the issuance, LABIXIAOXIN confirmed compliance with the Hong Kong Stock Exchange’s minimum 25 % public-float requirement.